Hemodynamic Effects of Glucagon: A Literature Review
Open Access
- 13 March 2018
- journal article
- review article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 103 (5) , 1804-1812
Abstract
Context Glucagon’s effects on hemodynamic parameters, most notably heart rate and cardiac contractility, are often overlooked. The glucagon receptor is a central target in novel and anticipated type 2 diabetes therapies, and hemodynamic consequences of glucagon signaling have therefore become increasingly important. In this review, we summarize and evaluate published studies on glucagon pharmacology with a focus on clinical hemodynamic effects in humans. Evidence Acquisition PubMed, Embase, and the Cochrane Library were searched for clinical studies concerning hemodynamic effects of glucagon (no year restriction). Papers reporting effects of a defined glucagon dose on any hemodynamic parameter were included. Reference searches were conducted in retrieved articles. Evidence Synthesis Hemodynamic effects of glucagon have been investigated mainly in cohort studies of patients suffering from heart failure receiving large glucagon bolus injections. The identified studies had shortcomings related to restricted patient groups, lack of a control group, randomization, or blinding. We identified no properly conducted randomized clinical trials. The majority of human studies report stimulating effects of pharmacological glucagon doses on heart rate, cardiac contractility, and blood pressure. The effects were characterized by short duration, interindividual variation, and rapid desensitization. Some studies reported no measurable effects of glucagon. Conclusions The level of evidence regarding hemodynamic effects of glucagon is low, and observations in published studies are inconsistent. Actual effects, interindividual variation, dose-response relationships, and possible long-term effects of supraphysiological glucagon levels warrant further investigation.Keywords
This publication has 100 references indexed in Scilit:
- Glucose-Dependent Insulinotropic PolypeptideDiabetes, 2011
- Glucagon and a glucagon‐GLP‐1 dual‐agonist increases cardiac performance with different metabolic effects in insulin‐resistant heartsBritish Journal of Pharmacology, 2011
- Low Sensitivity of Glucagon Provocative Testing for Diagnosis of PheochromocytomaThe Journal of Clinical Endocrinology & Metabolism, 2010
- The Funny CurrentDrugs, 2007
- Glucagon and the a CellNew England Journal of Medicine, 1981
- Glucagon in Heart Failure and in Cardiogenic ShockCirculation, 1972
- Hemodynamic Evaluation of Glucagon in Symptomatic Heart DiseaseCirculation, 1971
- Effects of Glucagon on Myocardial Oxygen Consumption and Coronary Blood Flow in Man and in DogCirculation, 1970
- The Effect of Glucagon on the Coronary Circulation in ManCirculation, 1969
- Hemodynamic Effects of Glucagon in Patients with Heart DiseaseCirculation, 1969